Keyword Analysis & Research: arsenalbio
Keyword Research: People who searched arsenalbio also searched
Search Results related to arsenalbio on Search Engine
-
Arsenal Bio • Engineering Hope
https://arsenalbio.com/
WEBBold Ideas. Breakthrough Discoveries. With our programmable and computationally driven approach, our team is engineering medicines with the goal to attack cancer’s inherent multi-faceted nature and overcome the challenges of addressing solid tumors with cell therapy. Our Technology.
DA: 75 PA: 5 MOZ Rank: 40
-
About • Arsenal Bio
https://arsenalbio.com/about/
WEBArsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer. With our programmable and computationally driven approach, we aim for enhanced and broader activity and safety profile.
DA: 66 PA: 32 MOZ Rank: 10
-
Pipeline • Arsenal Bio
https://arsenalbio.com/pipeline/
WEBArsenalBio and Genentech are deploying synergistic capabilities to study effective T cell-based modifications and develop new understandings of their effects through preclinical analysis. Both companies will leverage these learnings in the development of future therapeutic candidates.
DA: 23 PA: 56 MOZ Rank: 47
-
Arsenal Biosciences, Inc. | LinkedIn
https://www.linkedin.com/company/arsenalbio
WEBArsenalBiosciences, Inc., is a privately held, clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer.
DA: 97 PA: 5 MOZ Rank: 27
-
Arsenal Biosciences Closes $220 Million Series B ... - Business …
https://www.businesswire.com/news/home/20220906005150/en/Arsenal-Biosciences-Closes-220-Million-Series-B-Financing-to-Advance-Programmable-Cell-Therapy-Programs-into-Clinical-Development
WEBSep 6, 2022 · Arsenal Biosciences, Inc. (ArsenalBio), headquartered in South San Francisco, Calif., is a privately held programmable cell therapy company discovering and developing a pipeline of...
DA: 23 PA: 30 MOZ Rank: 21
-
ArsenalBio Announces Presentation of Six Abstracts at AACR …
https://www.businesswire.com/news/home/20230414005113/en/ArsenalBio-Announces-Presentation-of-Six-Abstracts-at-AACR-Annual-Meeting-Highlighting-Programmable-Cell-Therapy-Progress
WEBApr 14, 2023 · ArsenalBio will disclose features and findings of AB-2100, a novel integrated circuit T cell therapeutic candidate engineered for the treatment of clear cell renal cell carcinoma. This is the...
DA: 80 PA: 41 MOZ Rank: 9
-
ArsenalBio Announces First Patient Dosed in Phase 1 Clinical …
https://innovation.ucsf.edu/news/arsenalbio-announces-first-patient-dosed-phase-1-clinical-trial-treatment-ovarian-cancer
WEBJan 6, 2023 · Arsenal Biosciences, Inc., a clinical stage, programmable cell therapy company engineering advanced CAR T cell therapies for solid tumors, founded by UCSF Researchers Alex Marson, PhD, and Kole Roybal, PhD, today announced that the first patient has been dosed with AB-1015 in a Phase 1, first-in-human clinical trial for …
DA: 30 PA: 51 MOZ Rank: 77
-
ArsenalBio Announces Presentations Highlighting Preclinical …
https://www.businesswire.com/news/home/20230516005255/en/ArsenalBio-Announces-Presentations-Highlighting-Preclinical-Data-on-AB-1015-and-AB-2100-at-ASGCT-Annual-Meeting/
WEBMay 16, 2023 · ArsenalBio’s oral abstract session will detail preclinical data on AB-1015, currently in phase 1 clinical development ( NCT05617755) for patients with ovarian cancer, that incorporates...
DA: 97 PA: 42 MOZ Rank: 72
-
ArsenalBio - Crunchbase Company Profile & Funding
https://www.crunchbase.com/organization/arsenalbio
WEBArsenalBio is a programmable cell therapy company that offers advanced CAR T-cell therapies for solid tumors. South San Francisco, California, United States. 251-500. Series B. Private. www.arsenalbio.com. 42,467. Total Funding Amount. Unlock for free. Contacts 200. Employee Profiles 7. Investors 17. Similar Companies 11.
DA: 34 PA: 92 MOZ Rank: 73
-
Thermo Fisher (TMO) Partners With ArsenalBio for Cancer R&D
https://www.nasdaq.com/articles/thermo-fisher-tmo-partners-with-arsenalbio-for-cancer-rd
WEBMarch 30, 2023 — 07:45 am EDT. Written by Zacks Equity Research for Zacks -> Thermo Fisher Scientific TMO recently announced a strategic collaboration with the privately held, programmable...
DA: 78 PA: 50 MOZ Rank: 6
